SUBCELLULAR LOCALIZATION
| plasma membrane
|
| intracellular
|
| intracellular,cytoplasm,cytoskeleton
|
| intracellular,nucleus,nucleoplasm
|
text
| with isoforms FHL1A, FHL1B,(SLIM1) localizing at focal adhesions and SLIM3 (slimmer) in the nucleus of myoblasts and cytoplasm of myotubes |
|
can be localized to the sarcolemma, sarcomere, and nucleus of muscle cells |
|
localized within the cytoskeleton and the nucleus and can shuttle between these compartments |
|
mainly localize to the sarcomeric I-band, but also to a lesser extent to the M-band of the sarcomere in skeletal myocytes |
basic FUNCTION
| sugesting distinct roles in the cytoskeleton and in nuclear-cytoplasmic communication |
|
probably related to neural differentiation |
|
playing a role in the development and maintenance of muscle tissue, in sarcomere synthesis and assembly |
|
regulator of myosin-binding protein C activity and playinga role in sarcomere assembly |
|
LIM domain protein that suppresses the RBPJ-mediated transcriptional activation |
|
might inhibit the RBPJ-mediated transactivation through intracellular domain of Notch by recruiting co-suppressors such as CBX4 |
|
implicated in sarcomere assembly by interacting with myosin binding protein-C |
|
suggested to contribute to sarcomere synthesis, assembly and biomechanical stress sensing |
|
cooperative regulation of VEGFA signaling by FHL1 and SMAD4 was evidenced, which may provide a novel regulation mechanism underlying cancer development and progression |
|
FHL1 and FHL2 are novel cardiac PRKD1 partners, which differentially facilitate PRKD1 activation and HDAC5 phosphorylation by distinct neurohormonal stimuli, but are unlikely to regulate MEF2A-driven transcriptional reprogramming |
|
can be an acting molecule mediating both signaling pathways during osteogenesis |